Empowered Patient Podcast

Leveraging AI and Cohort Data for Precision Oncology Improves Insights and Efficacy of Treatment Plans with Kathy Ford Ronin

Informações:

Synopsis

Kathy Ford is the Chief Product and Strategy Officer at Ronin, applying AI and deep data mining to determine relevant cohorts to develop better cancer treatment plans.  Looking at patient-specific data, including genetics, comorbidities, and risk factors, allows medical oncologists and patients to predict results and more accurately anticipate and prevent adverse events. The Ronin AI-based solution also educates patients in real-time as they go through their treatment. Kathy explains, "At Ronin, we are determined to leverage the power of all of the underutilized data in healthcare to better inform clinicians to make a more patient-specific decision faster, essentially, at the point of care. And we're starting in oncology to do so, the most complex disease. We are leveraging all the unclean and uncorrelated data, delivering it to the clinician, adding insights and intelligence, and speeding up decisions. We collaborated with MD Anderson to build the solution. So built with clinicians for clinicians. And we're